Use Of SB-705498 In The Acute Treatment Of Migraine
NCT00269022
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine, Acute
Interventions
DRUG:
SB-705498
Sponsor
GlaxoSmithKline